Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/08/2022 | Q2 2022 | -$1.70 | -$2.48 | -0.78 | $119,000 | |
05/10/2022 | Q1 2022 | -$1.51 | -$1.50 | 0.01 | $429,000 | |
02/28/2022 | Q4 2021 | -$1.39 | -$1.58 | -0.19 | $25,205 | |
11/09/2021 | Q3 2021 | -$1.27 | -$1.34 | -0.07 | $460,000 | |
08/09/2021 | Q2 2021 | -$1.21 | -$1.14 | 0.07 | $5.16 M | |
05/05/2021 | Q1 2021 | -$0.61 | -$0.73 | -0.12 | $25.21 M | |
03/01/2021 | Q4 2020 | -$0.92 | -$1.02 | -0.1 | $0 | |
11/12/2020 | Q3 2020 | -$0.54 | -$0.42 | 0.12 | $25.00 M | |
08/10/2020 | Q2 2020 | -$0.89 | -$0.82 | 0.07 | $0 | |
05/12/2020 | Q1 2020 | -$0.66 | -$1.69 | -1.03 | $0 | |
03/17/2020 | Q4 2019 | -$0.58 | $0 | |||
11/04/2019 | Q3 2019 | -$0.55 | -$0.63 | -0.08 | $0 | |
08/06/2019 | Q2 2019 | -$0.65 | -$0.70 | -0.05 | $0 | |
05/31/2019 | Q1 2019 | -$0.69 | -$0.49 | 0.2 | $0 | |
12/30/2018 | Q4 2018 | -$0.32 | $0 | |||
09/29/2018 | Q3 2018 | -$0.40 | $0 | |||
06/29/2018 | Q2 2018 | -$0.34 | $0 | |||
03/30/2018 | Q1 2018 | -$0.32 | $0 |
Turning Point Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 8th, 2022 based off last year's report dates.
The conference call for Turning Point Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Turning Point Therapeutics, Inc.'s latest earnings report can be read online.
Turning Point Therapeutics, Inc. (:TPTX) has a recorded annual revenue of $30.83 M.
Turning Point Therapeutics, Inc. (:TPTX) has a recorded net income of $30.83 M. Turning Point Therapeutics, Inc. has generated $-5.79 earnings per share over the last four quarters.
Turning Point Therapeutics, Inc. (:TPTX) has a price-to-earnings ratio of -13.03 and price/earnings-to-growth ratio is -0.13.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED